.AstraZeneca has discussed a very early look at the efficiency of its own internal antibody-drug con...
.After declaring a period 3 launch based on positive midstage outcomes, iTeos as well as GSK are act...
.The FDA must be more available as well as collective to discharge a rise in commendations of rare h...
.It is actually an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Re...
.Atea Pharmaceuticals' antiviral has fallen short another COVID-19 trial, but the biotech still keep...
.Neurocrine Biosciences' mental illness plan pivot has actually fallen short. The biotech was actual...
.Sanofi has created an overdue entrance to the radioligand celebration, paying for 100 million europ...
.After F2G's first try to obtain a brand-new class of antifungal to market was actually wrecked by t...
.Moderna has promised to cut R&D spending through $1.1 billion through 2027. The selection to ret...
.Merely four months after Sanofi wager $80 million in upfront money on Fulcrum Rehabs' losmapimod, t...